Javascript must be enabled to continue!
Co-infection with Influenza A and COVID-19
View through CrossRef
COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China. It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO. Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts. We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection.
Title: Co-infection with Influenza A and COVID-19
Description:
COVID-19, also called severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan, China.
It has caused significant morbidity and mortality worldwide and has been declared a global pandemic by the WHO.
Influenza occurs mainly during the winter, with the burden of disease determined by several factors, including the effectiveness of the vaccine that season, the characteristics of the circulating viruses, and how long the season lasts.
We describe the case of a 66-year-old woman who was diagnosed with influenza A and COVID-19 co-infection.
Related Results
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Coronavirus disease 2019 (COVID-19) is characterized by a high incidence of acute respiratory failure. The underlying immunopathology of that failure and how it compares to other c...
Vaksin Influenza dan COVID-19 : sebuah tinjauan
Vaksin Influenza dan COVID-19 : sebuah tinjauan
<p>Pendahuluan: SARS-CoV-2 merupakan agen virus penyebab COVID-19, penyakit yang menjadi wabah secara global. Gejala infeksi COVID-19 beragam, sebagian besar dengan derajat r...
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: BordersâHemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated against Influenza Pediatric Patients in Two In-fluenza seasons after the COVID-19 pandemic.The Impact of Comorbidities on Hospitalization for Influenza in Children.
Antiviral therapy such as Oseltamivir has been recommended for hospitalized children with suspected and confirmed influenza for almost 20 years. The therapy is officially authorize...
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Burden and seasonality of medically attended influenza like illness (ILI) in Ethiopia, 2012 to 2017
Abstract
Background
The influenza virus spreads rapidly around the world in seasonal epidemics, resulting in significant morbidity and mortality. In...
Avian Influenza Viruses
Avian Influenza Viruses
Abstract
Avian influenza viruses comprise all recognised antigenic subtypes within the genus
Influenza A
...

